Eptinezumab in Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (PROMISE-1)

Cephalalgia - United States
doi 10.1177/0333102420905132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

ADHD and EEG-neurofeedback: A Double-Blind Randomized Placebo-Controlled Feasibility Study

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2010English

Different Inhaler Devices in Acute Asthma Attacks: A Randomized, Double-Blind, Placebo-Controlled Study

Jornal de Pediatria
Child HealthPediatricsPerinatology
2005English

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)

PLoS ONE
Multidisciplinary
2013English

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Hepatitis Monthly
HepatologyInfectious Diseases
2016English

Ketanserin in Essential Hypertension: A Double-Blind, Placebo-Controlled Study.

Postgraduate Medical Journal
Medicine
1985English

Fluoxetine for Depression in Diabetes: A Randomized Double-Blind Placebo-Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2000English

Randomized, Double Blind, Placebo-Controlled Study on Long-Term Prophylaxis With Echinacea Purpurea

Reviews on Clinical Pharmacology and Drug Therapy
2012English

A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome

Gastroenterology
HepatologyGastroenterology
2008English

Glimepiride Treatment and IGF-I in Adolescents With Type 1 Diabetes: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy